Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Decreased by Gilder Gagnon Howe & Co. LLC

Gilder Gagnon Howe & Co. LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 473,846 shares of the medical equipment provider's stock after selling 2,814 shares during the quarter. Intuitive Surgical makes up approximately 2.7% of Gilder Gagnon Howe & Co. LLC's investment portfolio, making the stock its 6th largest position. Gilder Gagnon Howe & Co. LLC owned about 0.13% of Intuitive Surgical worth $247,329,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Summit Securities Group LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 2,401 shares of the firm's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now owns 353 shares of the company's stock, valued at $205,093. This trade represents a 87.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 30,913 shares of company stock worth $15,981,143. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have commented on ISRG shares. UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Bernstein Bank upped their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Finally, Evercore ISI lowered their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Trading Up 0.2 %

Shares of ISRG traded up $1.07 during trading hours on Wednesday, reaching $515.96. The company had a trading volume of 1,048,553 shares, compared to its average volume of 1,617,583. The firm has a 50 day simple moving average of $508.20 and a 200-day simple moving average of $533.13. The company has a market capitalization of $184.93 billion, a price-to-earnings ratio of 80.49, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the firm posted $1.50 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.